Monoclonal Antibody Drugs Fail To Improve Alzheimer's Disease Symptoms
The investigational drugs gantenerumab and solanezumab – both monoclonal antibody (mAb) therapeutics – failed to slow cognitive decline in patients with dominantly inherited Alzheimer’s disease (DIAD), a new trial has found.
Bruker Daltonics and HealthLinx Expand Biomarker Discovery Collaboration
The companies with further develop biomarkers for a number of pregnancy complications.
Rules-Based Medicine and Multiplex Biosciences Merge
Merger extends R&D capabilities, product expertise and expands customer base.
onCore UK Licenses LabVantage's Sapphire™ BioBanking Solution to Support its Ambitious Cancer Biosample Resource
onCore UK will create and run a national biosample resource, collecting and storing tissue and blood samples donated by patients.
Kimball Genetics Launches the Warfarin Sensitivity DNA Test for Research
The Warfarin Sensitivity DNA Test determines the presence of specific variations in the CYP2C9 and VKORC1 genes that confer sensitivity to warfarin.
Genzyme Launches Cystic Fibrosis Gene Sequencing Test
CF gene sequencing detects the most common mutations, as well as less common mutations not included in the available mutation panels.
Myriad Genetics Sponsors Clinical Trial in Pancreatic Cancer
The trial will enroll patients with previously untreated, advanced or recurrent pancreatic cancer and a mutation in the BRCA2 gene.
TranSenda Announces Membership in BioIT Alliance
As a member of the BioIT Alliance, TranSenda will work in partnership with other science and technology industry leaders.
AviaraDx Announces Publication of Study with Baylor College of Medicine
The study demonstrates a two-gene ratio is a prognostic indicator of breast cancer recurrence risk.
Genomic Tests Guide Choice of Chemotherapy in Cancer Patients
The tests have the potential to save lives and reduce patients' exposure to the toxic side effects of chemotherapy.
Xenomics Announces Development of a Method for Isolation of Cell-Free Nucleic Acids From Urine
Prototype research kits approach commercialization phase and target the growing field of genomic-based molecular diagnostics.